These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21684486)

  • 1. Vitiligo in a patient receiving infliximab for refractory ulcerative colitis.
    Ismail WA; Al-Enzy SA; Alsurayei SA; Ismail AE
    Arab J Gastroenterol; 2011 Jun; 12(2):109-11. PubMed ID: 21684486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal vein thrombosis following infliximab treatment for severe left-sided ulcerative colitis.
    Veerappan SG; Kennedy M; O'Morain CA; Ryan BM
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):588-9. PubMed ID: 18467922
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab in ulcerative colitis.
    Aberra FN; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Dec; 35(4):821-36. PubMed ID: 17129815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.
    Su C; Salzberg BA; Lewis JD; Deren JJ; Kornbluth A; Katzka DA; Stein RB; Adler DR; Lichtenstein GR
    Am J Gastroenterol; 2002 Oct; 97(10):2577-84. PubMed ID: 12385442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab for the treatment of ulcerative colitis.
    Eshuis EJ; Bemelman WA; Stokkers PC
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):219-29. PubMed ID: 19485804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab.
    Fok KC; Ng WW; Henderson CJ; Connor SJ
    J Crohns Colitis; 2012 Jul; 6(6):708-12. PubMed ID: 22398084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
    Mocciaro F; Orlando A; Scimeca D; Cottone M
    Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab in the treatment of severe ulcerative colitis: a follow-up study.
    Kohn A; Prantera C; Pera A; Cosintino R; Sostegni R; Daperno M
    Eur Rev Med Pharmacol Sci; 2004; 8(5):235-7. PubMed ID: 15638237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of infliximab in ulcerative colitis].
    Tilg H; Feichtenschlager T; Knoflach P; Petritsch W; Schöfl R; Vogelsang H; Reinisch W
    Z Gastroenterol; 2007 Aug; 45(8):907-11. PubMed ID: 17701864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report: ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis.
    Kinnunen U; Färkkilä M; Mäkisalo H
    J Crohns Colitis; 2012 Jul; 6(6):724-7. PubMed ID: 22398069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab.
    Hassan C; Ierardi E; Burattini O; De Francesco V; Zullo A; Stoppino G; Panella C; Morini S
    Dig Liver Dis; 2007 Sep; 39(9):811-7. PubMed ID: 17652038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
    Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
    Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe rosacea in a patient on infliximab for ulcerative colitis: pathophysiological considerations.
    Kosmidou M; Gaitanis G; Nomikos K; Zioga A; Katsanos K; Bassukas ID; Tsianos E
    Acta Derm Venereol; 2009; 89(5):522-3. PubMed ID: 19734983
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome following infliximab therapy in children with ulcerative colitis.
    Hyams JS; Lerer T; Griffiths A; Pfefferkorn M; Stephens M; Evans J; Otley A; Carvalho R; Mack D; Bousvaros A; Rosh J; Grossman A; Tomer G; Kay M; Crandall W; Oliva-Hemker M; Keljo D; LeLeiko N; Markowitz J;
    Am J Gastroenterol; 2010 Jun; 105(6):1430-6. PubMed ID: 20104217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis].
    Ainsworth MA; Brynskov J
    Ugeskr Laeger; 2007 Feb; 169(9):789-91. PubMed ID: 17355841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
    Sandborn WJ; Rutgeerts P; Feagan BG; Reinisch W; Olson A; Johanns J; Lu J; Horgan K; Rachmilewitz D; Hanauer SB; Lichtenstein GR; de Villiers WJ; Present D; Sands BE; Colombel JF
    Gastroenterology; 2009 Oct; 137(4):1250-60; quiz 1520. PubMed ID: 19596014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.